Zentixol A Injection 50 mg/ml contains Zuclopenthixol, a potent typical antipsychotic belonging to the thioxanthene class. It is specifically formulated for parenteral administration and is used in the management of severe psychotic disorders where rapid symptom control is required. The injectable form provides long-acting antipsychotic effects, making it suitable for patients who are non-compliant with oral therapy or require immediate stabilization of acute psychotic episodes.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Therapeutic Class

• Typical Antipsychotic

• Thioxanthene Derivative

Pharmacology

Zuclopenthixol is a dopamine receptor antagonist, primarily acting at D1 and D2 receptors in the central nervous system. By blocking dopaminergic transmission in key areas of the brain, it reduces psychotic symptoms, including hallucinations, delusions, agitation, and aggression. Zuclopenthixol also exhibits antagonistic activity at alpha-adrenergic, histaminergic, and cholinergic receptors, contributing to sedation, reduced anxiety, and calming effects in acutely agitated patients.

The pharmacological profile of Zentixol A allows it to provide sustained antipsychotic action with slower onset of extrapyramidal side effects compared to some other typical antipsychotics, making it particularly useful in acute psychiatric care settings.

Indications

Zentixol A Injection is indicated for:

• Acute schizophrenia and other psychotic disorders requiring rapid symptom control

• Severe agitation, aggression, or hostility in psychotic patients

• Non-compliance with oral antipsychotics or when oral administration is not feasible

• Long-term maintenance therapy in stabilized patients through depot formulations

Dosage & Administration

• Adults: The recommended starting dose is individualized based on severity and prior response to antipsychotics.

• For acute agitation, doses are typically administered intramuscularly, with careful monitoring of cardiovascular and central nervous system effects.

• Dose titration may be required to achieve optimal symptom control while minimizing adverse effects.

• Elderly patients or those with significant hepatic, renal, or cardiac impairment require careful dose adjustment.

• Zentixol A should always be administered under the supervision of a qualified healthcare professional.

Contraindications

• Known hypersensitivity to Zuclopenthixol or any component of the formulation

• Severe cardiovascular disorders, including recent myocardial infarction or arrhythmias

• Severe CNS depression or comatose states

• Parkinson’s disease with severe motor symptoms

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Side Effects

Common side effects include:

• Sedation and drowsiness

• Orthostatic hypotension, dizziness

• Dry mouth, constipation

• Extrapyramidal symptoms (tremor, rigidity)

Serious adverse effects may include:

• Tardive dyskinesia (long-term risk)

• Neuroleptic malignant syndrome (rare but potentially fatal)

• Cardiac arrhythmias or myocarditis

Precautions & Warnings

• Monitor blood pressure, heart rate, and neurological status during treatment

• Caution in patients with hepatic or renal impairment, seizure disorders, or elderly individuals

• Avoid abrupt discontinuation; tapering may be required to prevent rebound psychosis

• Concomitant use with other CNS depressants or alcohol increases sedative effects

Pregnancy & Lactation

• Safety in pregnancy has not been established; use only if clearly necessary

• Zuclopenthixol may be excreted in breast milk; breastfeeding is not recommended during therapy

Storage

• Store below 30°C in a dry place

• Protect from light

• Keep out of reach of children.